Sagittal and transverse fluid attenuated inversion recovery (FLAIR) images were obtained in age-matched 16 normal individuals, and 24 patients with obstructive hydrocephalus. The inner (inferior) callosal surface, which is covered by ependyma, was electronically measured ranging from 0.15 to 0.25 cm
Huge craniopharyngioma: diffusion MRI and contrast-enhanced FLAIR imaging
✍ Scribed by R.N. Sener; S. Dzelzite; A. Migals
- Book ID
- 104350423
- Publisher
- Elsevier Science
- Year
- 2002
- Tongue
- English
- Weight
- 430 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0895-6111
No coin nor oath required. For personal study only.
✦ Synopsis
Craniopharyngiomas are most commonly located extraaxially in the suprasellar area. They are benign but aggressive neoplasms. An adult patient is reported to have a huge craniopharyngioma with gross extensions to the surroundings. In diffusion MRI, it had high signal for b 1000 mm 2 =s (true diffusion) images, and at the same time, high ADC values ( 2.12 and 2:27 £ 10 23 mm 2 =s; compared to that of normal cerebellar parenchyma 0.85 £ 10 23 mm 2 /s). In FLAIR images, obtained after administration of intravenous contrast medium, an intense, diffuse enhancement pattern was seen involving the viable tumor portions as well as the intratumoral ¯uid.
📜 SIMILAR VOLUMES
## Abstract Perturbations of renal and systemic pH accompany diseases of the kidney, such as renal tubular acidosis, and the ability to image tissue pH would be helpful to assess the extent and severity of such conditions. A dual‐contrast‐agent strategy using two gadolinium agents, the pH‐insensiti
## Purpose: To compare peak enhancement (pe), determined from dynamic contrast-enhanced (dce) magnetic resonance imaging (mri) and the magnetic resonance (mr) directionally-averaged apparent diffusion coefficient () in glandular versus stromal prostatic tissues and, with this comparison, to infer i
## Abstract ## Purpose: To evaluate the diagnostic ability of diffusion‐weighted imaging (DWI) and dynamic contrast‐enhanced imaging (DCEI) in combination with T2‐weighted imaging (T2WI) for the detection of prostate cancer using 3 T magnetic resonance imaging (MRI) with a phased‐array body coil.